OptimizeRx Corp
OPRX
Market Cap$198.39M
Close$
$-1.45
113.7% downside
Current Fair Value
113.7% downsideOvervalued by 113.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $198.39 Million |
|---|---|
| Enterprise Value | $220.76 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.03 |
| Beta | 1.36 |
| Outstanding Shares | 18,183,914 |
| Avg 30 Day Volume | 153,946 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -11.29 |
|---|---|
| PEG | -0.96 |
| Price to Sales | 3.51 |
| Price to Book Ratio | 1.76 |
| Enterprise Value to Revenue | 3.09 |
| Enterprise Value to EBIT | -12.6 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
ESG Score
No data
About OptimizeRx Corp
OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary ne...